Breaking News
Sandisk Stock Gets Sky-High Price Target Amid Chip Stock Rally The NAIC Data Breach: A Turning Point for Data Collection and Privacy in the Insurance Industry Ashleigh Gardner claims two strikes in one over! Iran war and AI boom drive wild ride on global markets Flener promoted to Associate Head Basketball Coach at Michigan Tech Aligned raises $1.19bn in asset-backed securities T1, Liquid reach Mid-Season Invitational play-in final Crowds outside Supreme Court cheer at birthright citizenship decision
Signalz Online
Vistagen Announces Topline and Post-Hoc Data from PALISADE-4 Phase 3 Public Speaking Challenge Trial of Fasedienol for the Acute Treatment of Social Anxiety Disorder
Biotech Clinical Trials

Vistagen Announces Topline and Post-Hoc Data from PALISADE-4 Phase 3 Public Speaking Challenge Trial of Fasedienol for the Acute Treatment of Social Anxiety Disorder

Source: news.google.com

Published: Jun 30, 2026 12:00

Read Original Source
Vistagen Announces Topline and Post-Hoc Data from PALISADE-4 Phase 3 Public Speaking Challenge Trial of Fasedienol for the Acute Treatment of Social Anxiety Disorder  Business Wire
Detailed source content is still being fetched from the original article. Use the source link above for the live story.

Courtesy Link

https://news.google.com/rss/articles/CBMixAJBVV95cUxNOUFNUHkxWHBYWjB2UU5ta2V3QzVCU0hCQm5iN3lwVDNzbW9HVXYzMk9IckNYZDVqSDY4bmlQRDV4ZFp6dGVOZFVWU0YyNUIxWWVOVk1vVHF5eHNaLW1SNU1jVzVXRVBIN1pkbTUtbXBhMlNDOURMOS03OUg1ZXlhTk81dTFJMHVWeHMtOTUtMklUZm1ZN2pyZl9IUGNDQ2NtbHQ3aktqODJabi1kM0xRR2tEb2NERlpiUWVuN19xc1JjT0RhUlZmd0stOHZsU0JlN2JiNDNYeFh3TnlaclVEekl2a1YxQ2tQbWx4bkpybk9NcllFUktFZzE3NjNyOU8xMU4wRGY2Q01WeGlRemoyTndNcnpndEtMaDBicDJZTTV6WXBBYlJTZGw3Q1BvUDBQN2ZTcGpxanhqTm82OFFiSktPZmE?oc=5

Related Stories

More from this topic and section

Add Shortcut

Add Newsfeed to your home screen

Open this site faster like an app from your phone home screen.

X in 3s